Moderna COVID Vaccine is 94.5% Effective

Moderna, Inc. (Nasdaq: MRNA) reported the results of its Phase 3 study of mRNA-1273 has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%. A secondary endpoint analyzed severe cases of COVID-19 and included 11 severe cases (as defined in the study protocol) in this first interim …

Read more

Eli Lilly COVID Antibody Treatment Gets Emergency FDA Authorization

U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Eli Lilly & Companies investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients. Bamlanivimab is authorized for patients with positive results of direct SARS-CoV-2 viral testing who are 12 years of age and older weighing at …

Read more

Three More Repurposed Drugs Identified as Useful Against COVID

Three drugs out of 4000 existing drugs were identified as possibly effective against COVID. They are candidates for clinical trials. They are the antimalarial drug amodiaquine, the anti-psychotic zuclopenthixol, and the blood pressure medication nebivolol. University of New Mexico researcher Oprea and his team published in ACS Pharmacology & Translational Science, reported that an older …

Read more

WHO Doctor Nabarro Says We Must Fight COVID Without Lockdowns

Dr. David Nabarro, World Health Organization special envoy on COVID, is arguing for the middle way to have robust defenses against the virus without using lockdowns as the primary control method. Nabarro says “The only time we believe a lockdown is justified is to buy you time to reorganize, regroup, rebalance your resources, protect your …

Read more

US 2020 GDP Could be -2% With Possible Pandemic Economic Recovery By End of 2021

The Philadelphia Federal Reserve published results of a survey of 35 economic forecasters on August 14, 2020. They predicted the US economy would expand at an annual rate of 19.1 percent in the third quarter. This was almost double the prediction of 10.6 percent from the last survey. The forecasters expected real GDP to decrease …

Read more

Supercomputer Model Identifies Pathways and Possible Weaknesses of COVID-19

Oak Ridge National Laboratory supercomputer modeling analysis suggests COVID-19 causes the inflammatory molecule bradykinin to run amuck in the human body. The Bradykinin storm cause gel to form in the lungs and the blood vessels to leak. The same analysis identifies about ten interventions to reduce the severity of COVID-19. An easy precaution is to …

Read more

COVID-19 First Generation Vaccines Should Halve the Risk of Infection

Dr. Amesh Adalja, a senior scholar with the Johns Hopkins Center for Health Security, reports that the first generation of COVID-19 vaccines will give people who have vaccinated a 50% lower chance of getting infected than somebody who hasn’t been vaccinated. US Operation Warp Speed is giving billions to private pharma companies to try to …

Read more

Blood Transfusions Help Reduce COVID-19 Mortality by 35%

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients. The tests on 70,000 people suggest that the blood transfusion can reduced COVID-19 mortality by 35%. This procedure is transferring antibodies in the blood of people who were infected with COVID-19 …

Read more